KalshiChiusoVerifica disponibilitàKYC richiestoDati di risoluzione verificatiBen calibratoQuesto mercato è chiuso e in attesa di una risoluzione confermata.
In attesa di risoluzione verificata
CoinRithm attende un regolamento confermato dal provider prima di trattare questo mercato come risolto.
Probabilità implicita attuale
before April 2027 69%In testa tra 6 esiti
before April 2027 69%Qualità del mercato
34 / 100
Bassa qualitàVolume 24h
—
Open interest
21,9K USD
Open interest medioDati di mercato
Aggiornato 11 minuti fa
24 mar 26, 14:00 UTC1 set 26, 14:00 UTC
Trend
before April 202769%
before 202751%
before December27%
before November6%
before OctoberPersa
before SeptemberPersa
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
How many human screwworm cases will be reported in the United States in 2026?
KalshiHow many tuberculosis cases will be reported in the United States in 2026?
KalshiWhat will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 24 months?
Manifold MarketsWill WHO classify the current hantavirus outbreak as a Public Health Emergency of International Concern by end of 2026?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWhich countries will have an Ebola case in 2026?
PolymarketRegole
La regola esatta di questo esito non è disponibile.
Regole per ogni esito
- before April 2027
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.
- before 2027
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
- before December
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Dec 1, 2026, then the market resolves to Yes.
- before November
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Nov 1, 2026, then the market resolves to Yes.
- before October
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
- before September
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.